These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 7677606)

  • 1. Modulation of the anti-Candida activity of apo-lactoferrin by dietary sucrose and tunicamycin in vitro.
    Nikawa H; Samaranayake LP; Hamada T
    Arch Oral Biol; 1995 Jun; 40(6):581-4. PubMed ID: 7677606
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effect of antifungal agents on the in vitro susceptibility of Candida albicans to apo-lactoferrin.
    Nikawa H; Samaranayake LP; Tenovuo J; Hamada T
    Arch Oral Biol; 1994 Oct; 39(10):921-3. PubMed ID: 7741664
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The fungicidal effect of human lactoferrin on Candida albicans and Candida krusei.
    Nikawa H; Samaranayake LP; Tenovuo J; Pang KM; Hamada T
    Arch Oral Biol; 1993 Dec; 38(12):1057-63. PubMed ID: 8141667
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The antifungal effect of lactoferrin and lysozyme on Candida krusei and Candida albicans.
    Samaranayake YH; Samaranayake LP; Wu PC; So M
    APMIS; 1997 Nov; 105(11):875-83. PubMed ID: 9393559
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fungicidal effect of human lactoferrin against Candida albicans.
    Soukka T; Tenovuo J; Lenander-Lumikari M
    FEMS Microbiol Lett; 1992 Jan; 69(3):223-8. PubMed ID: 1555756
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The in vitro lysozyme susceptibility of Candida species cultured in sucrose supplemented media.
    Samaranayake YH; MacFarlane TW; Samaranayake LP; Aitchison TC
    Microbios; 1993; 74(298):23-8. PubMed ID: 8336552
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vitro susceptibility of Candida species to lactoferrin.
    Xu YY; Samaranayake YH; Samaranayake LP; Nikawa H
    Med Mycol; 1999 Feb; 37(1):35-41. PubMed ID: 10200932
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effect of dietary carbohydrates on the in-vitro adhesion of Candida albicans to epithelial cells.
    Samaranayake LP; MacFarlane TW
    J Med Microbiol; 1982 Nov; 15(4):511-7. PubMed ID: 6757438
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of dietary carbohydrates on the in vitro epithelial adhesion of Candida albicans, Candida tropicalis, and Candida krusei.
    Pizzo G; Giuliana G; Milici ME; Giangreco R
    New Microbiol; 2000 Jan; 23(1):63-71. PubMed ID: 10946407
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The in vitro lysozyme susceptibility of Candida albicans cultured in carbohydrate-supplemented media.
    Samaranayake YH; MacFarlane TW; Aitchison TC; Samaranayake LP
    Oral Microbiol Immunol; 1993 Jun; 8(3):177-81. PubMed ID: 8233572
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Activated lactoferrin and fluconazole synergism against Candida albicans and Candida glabrata vaginal isolates.
    Naidu AS; Fowler RS; Martinez C; Chen J; Tulpinski J
    J Reprod Med; 2004 Oct; 49(10):800-7. PubMed ID: 15568403
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Enhanced anti-Candida activity of neutrophils and azole antifungal agents in the presence of lactoferrin-related compounds.
    Wakabayashi H; Okutomi T; Abe S; Hayasawa H; Tomita M; Yamaguchi H
    Adv Exp Med Biol; 1998; 443():229-37. PubMed ID: 9781363
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Salivary lactoferrin in HIV-infected children: correlation with Candida albicans carriage, oral manifestations, HIV infection and its antifungal activity.
    Alves TP; Simões AC; Soares RM; Moreno DS; Portela MB; Castro GF
    Arch Oral Biol; 2014 Aug; 59(8):775-82. PubMed ID: 24837476
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Candida and candidaemia. Susceptibility and epidemiology.
    Arendrup MC
    Dan Med J; 2013 Nov; 60(11):B4698. PubMed ID: 24192246
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Human apo-lactoferrin enhances angiogenesis mediated by vascular endothelial growth factor A in vivo.
    Norrby K
    J Vasc Res; 2004; 41(4):293-304. PubMed ID: 15192265
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Growth and adsorption of Streptococcus mutans 6715-13 to hydroxyapatite in the presence of lactoferrin.
    Visca P; Berlutti F; Vittorioso P; Dalmastri C; Thaller MC; Valenti P
    Med Microbiol Immunol; 1989; 178(2):69-79. PubMed ID: 2733635
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Human apo-lactoferrin as a physiological mimetic of hypoxia stabilizes hypoxia-inducible factor-1 alpha.
    Zakharova ET; Kostevich VA; Sokolov AV; Vasilyev VB
    Biometals; 2012 Dec; 25(6):1247-59. PubMed ID: 23001680
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Agglutination of Streptococcus mutans serotype C cells but inhibition of Porphyromonas gingivalis autoaggregation by human lactoferrin.
    Soukka T; Tenovuo J; Rundegren J
    Arch Oral Biol; 1993 Mar; 38(3):227-32. PubMed ID: 8387771
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lactoferrin iron levels affect attachment of Actinobacillus actinomycetemcomitans to buccal epithelial cells.
    Fine DH; Furgang D
    J Periodontol; 2002 Jun; 73(6):616-23. PubMed ID: 12083534
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synergistic anti-candida activities of lactoferrin and the lactoperoxidase system.
    Nakano M; Suzuki M; Wakabayashi H; Hayama K; Yamauchi K; Abe F; Abe S
    Drug Discov Ther; 2019; 13(1):28-33. PubMed ID: 30880319
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.